Undaria pinnatifida and Ascidian Shell Composition for Atopic Dermatitis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for atopic dermatitis often lead to adverse side effects and are not fully effective in managing the condition, which is characterized by inflammation, itching, and skin pigmentation, due to the involvement of immunological and non-immunological mechanisms, including abnormal activation of immune functions and cytokine production.
Innovation Solution
A composition containing Undaria pinnatifida Sporophyll extract and purified ascidian shell, with fucoidan and glycosaminoglycan as active ingredients, is developed to alleviate atopic dermatitis through anti-inflammatory and cell regeneration effects, usable in various forms such as food, cosmetics, or pharmaceuticals, with a preferred mixing ratio of 1:0.5 to 1:4.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If steroid treatment is used to treat atopic dermatitis, then anti-inflammatory effect is improved, but adverse side effects such as epidermal growth inhibition occur
Solution Approach 1:
The patent replaces conventional steroid medications with a natural composition derived from Undaria pinnatifida sporophyll and ascidian shell. This natural composition provides the necessary anti-inflammatory effect without the harmful side effects of steroids, effectively substituting a harmful substance with a safer alternative that achieves the same therapeutic goal.
Solution Approach 2:
The patent uses a composite composition comprising extract of Undaria pinnatifida sporophyll and ascidian shell. This composite material combines the beneficial properties of both natural sources to achieve enhanced anti-inflammatory and skin-regenerating effects while avoiding the adverse effects of synthetic steroids.
2Reliability
If conventional treatments are used to manage atopic dermatitis, then inflammation is suppressed, but treatment time increases and patient convenience deteriorates
Solution Approach 1:
The natural composition provides effective treatment for atopic dermatitis without requiring long-term or repeated applications of conventional medications. The composition addresses both immunological and non-immunological mechanisms, reducing overall treatment duration and improving patient convenience.
3Reliability
If immunological mechanisms are targeted to treat atopic dermatitis, then inflammatory response is reduced, but treatment complexity increases
Solution Approach 1:
The patent employs a composite natural composition that simultaneously addresses multiple pathological mechanisms of atopic dermatitis, including immunological pathways (Th2-related cytokines, IgE production) and non-immunological pathways (PAR-2 activation, inflammatory mediator production). This multi-target approach simplifies treatment by using a single composition rather than multiple complex therapies.
Data Source
AI summary
The present invention relates to a composition comprising an extract of a mixture of Undaria pinnatifida sporophylls and ascidian shells for treating atopic dermatitis, wherein the composition has the excellent effect of treating atopic dermatitis through the synergistic interaction of the anti-inflammatory effect of Undaria pinnatifida sporophylls and the cell regenerative effect of ascidian shells. The composition of the invention is not involved in the suppression of cytokine production. However, it is assumed that the composition has the effects of suppressing inflammation as well as regenerating skin.